Results 151 to 160 of about 22,586 (210)

Targeting uridine diphosphate glucuronosyltransferase 1A1 in liver disease: Current research and future directions. [PDF]

World J Gastroenterol
Park SC, Kim YJ, Kim JW.
europepmc   +1 more source

Recombinant production of amaranthin and other betalain variants with yeast cell factories. [PDF]

Synth Syst Biotechnol
Glitz C, Dyekjær JD, Solimando GMC, Avila Neto PM, Rago D, Babaei M, Borodina I.   +6 more
europepmc   +1 more source

Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro Evidence. [PDF]

Clin Drug Investig
Gassiot M, Brun P, Wauthier V, Da Silva F, Nicolas O, Hays S, Sultan E.   +6 more
europepmc   +1 more source

Is dolichol pathway dysfunction a significant factor in Alzheimer's disease? [PDF]

Inflammopharmacology
Schloss JV.
europepmc   +1 more source

Natural Product-Induced Modulation of Androstenone Metabolism in Porcine Hepatocytes. [PDF]

Animals (Basel)
Bone C, Squires EJ.
europepmc   +1 more source

Bisphenol A and its analogues in thyroid diseases: Evidence from dysfunction, autoimmunity, and cancer. [PDF]

iScience
Hao X, Cao H, Shi B, Bai C, Liu X, Meng X.   +5 more
europepmc   +1 more source

Functional consequences of urinary bladder cancer risk variants [PDF]

, 2013
Selinski, Silvia
core  

Mechanistic insights into atorvastatin-induced hepatotoxicity: molecular pathways, clinical relevance, and strategies for safer personalized therapy. [PDF]

Clin Exp Med
Abdel-Rasol MA, El-Sayed WM.
europepmc   +1 more source

Inspissated Bile Syndrome and Crigler-Najjar Syndrome Type II: When Two Rare Conditions Converge. [PDF]

Case Rep Pediatr
Sangsari R, Saeedi M, Mirnia K, Tafreshi F.   +3 more
europepmc   +1 more source